Zoetis Reports Strong Q4 Earnings

Animal health company exceeds Wall Street expectations for revenue and profit.

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Zoetis Inc., a leading animal health company, reported fourth-quarter profit of $603 million, or $1.37 per share. Adjusted earnings came in at $1.48 per share, topping the average estimate of $1.40 per share from 11 analysts surveyed. The company also posted revenue of $2.39 billion in the quarter, surpassing the $2.37 billion expected by nine analysts.

Why it matters

Zoetis' strong financial performance in Q4 demonstrates the continued demand for its animal health products and services, even amid broader economic challenges. As a major player in the growing animal health industry, Zoetis' results provide insight into the overall health of the sector.

The details

For the full year, Zoetis reported profit of $2.67 billion, or $6.02 per share, on revenue of $9.47 billion. Looking ahead, the company expects full-year 2023 earnings in the range of $7 to $7.10 per share, with revenue between $9.82 billion and $10.03 billion.

  • Zoetis reported its Q4 2022 earnings on February 12, 2026.

The players

Zoetis Inc.

A leading global animal health company that develops and manufactures a diverse portfolio of animal health medicines and vaccines.

Got photos? Submit your photos here. ›

The takeaway

Zoetis' strong financial performance in Q4 2022 highlights the continued growth and resilience of the animal health industry, even in challenging economic conditions. The company's positive outlook for 2023 suggests it is well-positioned to capitalize on ongoing demand for its products and services.